Vivanza Biosciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue increased to ₹7.62 crore in Q3 2023, showing growth from ₹6.56 crore in Q2 2023.
Operating profit margin improved to 2.74% in Q3 2023, up from 2.88% in Q2 2023.
Net profit of ₹0.26 crore in Q3 2023 indicates a positive turnaround from losses in earlier quarters.

NEGATIVES

Profit before tax decreased significantly to ₹0.26 crore in Q3 2023 from ₹0.21 crore in Q2 2023.
Expenses rose to ₹7.41 crore in Q3 2023, higher than Q2 2023's ₹6.37 crore, impacting profitability.
EPS remains low at ₹0.07 in Q3 2023, reflecting ongoing challenges in achieving consistent profitability.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	9.23	7.62	6.56	4.42	2.44	3	1.50	0.48	8.94
Expenses	8.64	7.30	6.27	4.56	2.08	2.89	1.38	1.44	8.79
Operating Profit	0.59	0.32	0.29	-0.14	0.36	0.11	0.12	-0.95	0.15
Other Income	0.01	0.05	0.02	-0.03	0	0	0.01	0.05	0.02
Interest	0.11	0.11	0.10	0.09	0.09	0.09	0.09	0.08	0.08
Depreciation	0	0	0	0.01	0	0	0	0	0
Profit Before Tax	0.49	0.26	0.21	-0.27	0.27	0.01	0.04	-0.99	0.09
Tax	0	0	0	0.15	0	0	0	0.01	0
Net Profit	0.49	0.26	0.21	-0.41	0.27	0.02	0.04	-1	0.09
Eps in Rs	0.12	0.07	0.05	-0.10	0.07	0	0.01	-0.25	0.02